Original Article IL-17A promotes osteoclast formation via inducing RANKL in synovial cells

Furthermore, the expression of ITGB1 at both mRNA and protein levels was markedly downregulated in miR-183 mimic group and dramatically upregulated in miR-183 inhibitor group

Using IHC, we assessed the IL-11 and IL-11Ra protein expressions in human tumor tissues from 124 breast cancer patients.. IHC examina- tion showed that IL-11 was predominantly

After miR-34a mimic or its control was transfected into HCAECs cells, the mRNA level expressions of TNF-α (A), IL-6 (B) and IL-1β (C) were de - tected by RT-PCR. Data were

In order to probe into whether hypoxia regu- lates cervical cancer cells through IL-8 signals, we pre-treated HeLa and SiHa cells with anti- human IL-8 neutralizing antibody (0,

Catalpol significantly increased RGCs survival rate, declined LDH and ROS content, enhanced SOD activity, reduced TNF-α and IL-1β secretion, decreased NF-κB mRNA and

Results: IL-9 mRNA abundance and protein secretion were both markedly reduced following treatment of activated PBMC with Dex.. mRNA levels were reduced to 0.7% of control values

In previous work, we showed that IL-6 upregulated IL-17A by inducing Th17 or Foxp3+ Treg cell differentiation in vitro or in the peripheral blood of DLBCL patients, thereby pro-

We show that, as compared with the mono-specific inhibitors of IL-17A (V3) and MMP-9 (N-TIMP2), the engineered bi-specific fusion protein inhibits both MMP-9 activation